NPPB and AL amyloidosis: Revised Mayo staging is the most widely used, well-validated prognostic system in AL amyloidosis, incorporating the cardiac biomarkers troponin T (TnT) and N-terminal pro-brain natriuretic peptide (NT-proBNP)1.